Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: Results from the EBMT IDWP01 trial

Vaccine

Volumn 28, Issue 15, 2010, Pages 2730-2734

  Cordonnier, Catherine ^a   Labopin, Myriam ^b   Chesnel, Virginie ^b   Ribaud, Patricia ^c   Camara, Rafael De La ^d   Martino, Rodrigo ^e   Ullmann, Andrew J ^f   Parkkali, Terttu ^g   Locasciulli, Anna ^h   Yakouben, Karima ⁱ   Pauksens, Karlis ^j   Bonnet, Eric ^k   Einsele, Hermann ^l   Niederwieser, Dietger ^m   Apperley, Jane ⁿ   Ljungman, Per ^o  

^a HENRI MONDOR HOSPITAL   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^e Hospital Sant Pau   (Spain)

^f JOHANNES GUTENBERG UNIVERSITY   (Germany)

^g HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^h San Camillo Fortanini Hospital   (Italy)

ⁱ HÔPITAL ROBERT DEBRÉ   (France)

^j UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^k Wyeth Pharmaceuticals Medical Department   (France)

^l University Hospital   (Germany)

^m UNIVERSITY HOSPITAL LEIPZIG   (Germany)

ⁿ HAMMERSMITH HOSPITAL   (United Kingdom)

^o KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

more..

Author keywords

Allogeneic stem cell transplantation; Pneumococcal infection; Pneumococcal vaccine

Indexed keywords

BACTERIUM ANTIBODY; PNEUMOCOCCAL CONJUGATE VACCINE; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ACTIVE IMMUNIZATION; ADOLESCENT; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIBODY TITER; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; FEMALE; GRAFT RECIPIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SEROTYPE;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMOCOCCAL VACCINES; STEM CELL TRANSPLANTATION; STREPTOCOCCUS PNEUMONIAE; TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS; VACCINATION; YOUNG ADULT;

EID: 77949273845     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.01.025     Document Type: Article

References (13)

1. Winston D.J., Ho W.G., Schiffman G., Champlin R.E., Feig S.A., and Gale R.P. Pneumococcal vaccination of recipients of bone marrow transplants. Arch Intern Med 143 (1983) 1735-1737
2. Hammarstrom V., Pauksen K., Azinge J., Oberg G.L.P., and Ljungman P. Pneumococcal immunity and response to immunization with pneumococcal vaccine in bone marrow transplant patients: the influence of graft versus host reaction. Support. Care Cancer 1 (1993) 195-199
3. Avanzini M.A., Carra A.M., Maccario R., Zecca M., Zecca G., Pession A., et al. Antibody response to pneumococcal vaccine in children receiving bone marrow transplantation. J Clin Immunol 15 (1995) 137-144
4. Molrine D., Antin J.H., Guinan E.C., Soiffer R.J., MacDonald C., Malley R., et al. Donor immunization with pneumococal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic stem cell transplantation. Blood 101 (2003) 831-836
5. Cordonnier C., Labopin M., Chesnel V., Ribaud P., De La Camara R., Martino R., et al. Randomised study of early versus late immunisation with pneumococcal conjugate vaccine after allogeneic stem cell transplantation. Clin Infect Dis 48 (2009) 1392-1401
6. Meisel R., Kuypers L., Dirksen U., Schubert R., Gruhn B., Strauss G., et al. Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic stem cell transplantation. Blood 109 (2007) 2322-2326
7. Kumar D., Chen M.H., Welsh B., Siegal D., Cobos I., Messner H.A., et al. A randomized, double blind trial of pneumococcal vaccination in adult allogeneic stem cell transplant donors and recipients. Clin Infect Dis 45 (2007) 1576-1582
8. ®), the National Marrow Donor Program (NMDP), the European Blood and Marrow Transplant Group (EBMT), the American Society of Blood and Marrow Transplantation (ASBMT), the Canadian Blood and Marrow Transplant Group (CBMTG), the Infectious Disease Society of America (IDSA), the Society for Healthcare Epidemiology of America (SHEA), the Association of Medical Microbiology and Infectious Diseases Canada (AMMI), and the Centers for Disease Control and Prevention (CDC) Biology and Bone Marrow Transplant 2009;15:1143-1238.
9. Barra A., Cordonnier C., Precziosi M.P., Intrator L., Hessel L., Fritzell B., et al. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients. J Infect Dis 166 (1992) 1021-1028
10. De Roux A., Schmöele-Thoma B., SIber G.R., Hackell J.G., Kuhnke A., Ahlers N., et al. Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory. Clin Infect Dis 46 (2008) 1015-1023
11. Engelhard D., Cordonnier C., Shaw P.J., Parkkali T., Guenther C., Martino R., et al. Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey. Br J Haematol 117 (2002) 444-450
12. Kumar D., Humar A., Plevneshi A., Siegal D., Franke N., Green K., et al. Invasive pneumococcal disease in adult hematopoietic stem cell transplant recipients: a decade of prospective population-based surveillance. Bone Marrow Transplant 41 (2008) 743-747
13. Debbache K., Varon E., Hicheri Y., Legrand P., Donnay J.L., Ribaud P., et al. Epidemiology of S. pneumoniae infection in hematology patients in Ile de France: serotypes covered by the polysaccharide 23-valent (PS23) and the heptavalent conjugate vaccine. Clin Microbiol Infect 15 (2009) 865-868